Investor
Overview

Company Profile

Nuwellis is an early stage company focused on commercializing the Aquadex FlexFlow® System. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. Nuwellis is listed on the NASDAQ Capital Market.

Annual Letter to Stakeholders, April 13, 2021

Jun 20, 2021 7:56 AM EDT

Data provided by Refinitiv. Minimum 15 minutes delayed.

Stock information

 

 

History of Transforming Care

Our passion and expertise are grounded in a rich history of innovation and evolution. Since our inception in 1999, we have focused our efforts on understanding and meeting the critical needs associated with the treatment of fluid overload.

 

 

 

 

Events & Presentations

More events are coming soon.

jump